Technical Analysis for VIVO - Meridian Bioscience Inc.

Grade Last Price % Change Price Change
D 19.07 2.58% 0.48
VIVO closed up 2.58 percent on Friday, May 14, 2021, on 66 percent of normal volume.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Flat
Historical VIVO trend table...

Date Alert Name Type % Chg
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Oversold Stochastic Weakness 0.00%
Wide Bands Range Expansion 2.58%
Oversold Stochastic Weakness 2.58%
Inside Day Range Contraction 5.89%
Wide Bands Range Expansion 5.89%
Oversold Stochastic Weakness 5.89%
Wide Bands Range Expansion 2.47%
Lower Bollinger Band Touch Weakness 2.47%
Oversold Stochastic Weakness 2.47%
Older End-of-Day Signals for VIVO ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Meridian Bioscience Inc. Description

Meridian Bioscience, Inc., a life science company, develops, manufactures, sells, and distributes clinical diagnostic test kits primarily for gastrointestinal, viral, respiratory, and parasitic infectious diseases. The company's diagnostic products principally include C. difficile for the detection of gastrointestinal diseases, such as antibiotic-associated diarrhea; Rotavirus and Adenovirus products for pediatric diarrhea detection; H. pylori for the detection of stomach ulcers; EHEC test for the detection of Enterohemorrhagic E. coli infection and Campy for the detection of Campylobacter jejuni; and Group A Strep and Group B Strep tests for the detection of streptococcus bacterial infections. Its diagnostic products are also used in the detection of viral diseases, such as mononucleosis, herpes simplex, chicken pox, and shingles; organ transplant infections; parasitic diseases, including giardiasis, cryptosporidiosis, and lyme; and respiratory diseases, such as pneumonia, valley fever, influenza, and respiratory syncytial virus. The company also offers transport media that store and preserve specimen samples from patient collection to laboratory testing; and bulk antigens, antibodies, PCR/qPCR reagents, nucleotides, competent cells, and bioresearch reagents used by researchers and other diagnostic companies. In addition, it engages in the contract development and manufacture of proteins and other biologicals under cGMP conditions for use by biopharmaceutical and biotechnology companies engaged in research for new drugs and vaccines; and sale and distribution of diagnostic test kits manufactured by third-party vendors. The company markets its products through direct sales force and independent distributors primarily to hospitals, reference laboratories, and research customers in the United States, Asia, Canada, South America, Australia, Europe, Africa, and the Middle East. Meridian Bioscience, Inc. was founded in 1976 and is headquartered in Cincinnati, Ohio.


Classification

Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Medicine Biotechnology Infectious Diseases Antibodies Gastrointestinal Antibiotic Influenza Diagnostic Products Ulcer Bacterial Infections Respiratory Disease Diarrhea Gastrointestinal Disease Ingles Gastrointestinal Diseases Herpes Respiratory Diseases Shingles Fever Viral Disease Herpes Simplex Pneumonia Viral Diseases Nucleotides Zoonoses Organ Transplant Campylobacter Feces Mononucleosis Waterborne Diseases

Is VIVO a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 30.65
52 Week Low 12.98
Average Volume 720,237
200-Day Moving Average 20.46
50-Day Moving Average 23.09
20-Day Moving Average 20.28
10-Day Moving Average 19.07
Average True Range 1.03
ADX 29.93
+DI 17.86
-DI 30.61
Chandelier Exit (Long, 3 ATRs ) 21.50
Chandelier Exit (Short, 3 ATRs ) 20.69
Upper Bollinger Band 23.27
Lower Bollinger Band 17.29
Percent B (%b) 0.3
BandWidth 29.47
MACD Line -1.38
MACD Signal Line -1.34
MACD Histogram -0.0339
Fundamentals Value
Market Cap 817.39 Million
Num Shares 42.9 Million
EPS 1.07
Price-to-Earnings (P/E) Ratio 17.82
Price-to-Sales 3.19
Price-to-Book 3.26
PEG Ratio 1.33
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 19.85
Resistance 3 (R3) 19.78 19.46 19.72
Resistance 2 (R2) 19.46 19.26 19.49 19.68
Resistance 1 (R1) 19.26 19.13 19.36 19.33 19.63
Pivot Point 18.94 18.94 18.98 18.97 18.94
Support 1 (S1) 18.74 18.74 18.84 18.81 18.51
Support 2 (S2) 18.42 18.62 18.45 18.46
Support 3 (S3) 18.22 18.42 18.42
Support 4 (S4) 18.29